Precision medicine at Blue Latitude Health

Blue Latitude Health|7th November 2019

Many stakeholders are confused by precision medicines, including patients and healthcare professionals. So, how can industry help them to navigate this complexity? At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video below to get a run down on three core components to consider when commercialising these innovative products.

Maximising the commercial potential of the pharmaceutical pipeline

Blue Latitude Health|3rd April 2020

Decisions made early in the drug development process can define the limits of what’s possible for products and portfolios. So, why aren’t commercial teams always involved in these early conversations? In this Q&A we deep dive into early stage strategy, including how to break down these siloes and rethink drug development and clinical trial design.

read more

In-progress treatments for COVID-19: an attempt to simplify things

Manos Mastorakis|27th March 2020

Senior Associate Consultant, Manos Mastorakis, takes a look at a number of COVID-19 drugs that are already registered in clinical trials, providing analysis aiming to simplify the current landscape.

read more

Why I became a multiple myeloma patient advocate

Imogen Coupe|6th March 2020

BLH speaks to MM patient advocate, Peter McCleave, to find out how he has fought to remain positive throughout his treatment journey while simultaneously leading a successful campaign to get more people to sign up to be a blood stem cell donor.

read more